Product Information
CYTOMEL 25 MCG TABLET is a brand product labeled by Pfizer Inc., priced at $0.5295 per EA under NDC 60793011601. Its NADAC has been published 388 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the liothyronine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 ug/1
Manufacturer
Pfizer Inc.NDC
60793011601
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LIOTHYRONINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA010379On Market Since
5/8/1956
Pharmacological Classes
Price Statistics
The NADAC for CYTOMEL 25 MCG TABLET has been published 388 times since Nov 28, 2013, and over the history we have for it it has declined 58.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5295 per EA |
|---|---|
| All-time high | $2.4173 (Jan 16, 2019) |
| All-time low | $0.5086 (Mar 20, 2024) |
| 52-week high | $0.5360 |
| 52-week low | $0.5090 |
| Median price | $1.4555 |
| Average price | $1.4187 |
| Largest weekly change | -79.0% (Mar 20, 2024) |
| Weeks tracked | 388 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYTOMEL 25 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYTOMEL 25 MCG TABLET, manufactured by Pfizer Inc., is $0.5295 per EA (NDC 60793011601), effective Jun 24, 2026.
How has the price of CYTOMEL 25 MCG TABLET changed over time?
Over the history we have for it, the NADAC for CYTOMEL 25 MCG TABLET has declined 58.2%. It has been tracked across 388 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYTOMEL 25 MCG TABLET?
Since Nov 28, 2013, the NADAC for CYTOMEL 25 MCG TABLET has ranged from a low of $0.5086 (Mar 20, 2024) to a high of $2.4173 (Jan 16, 2019), with a median of $1.4555 per EA.
Are there cheaper alternatives to CYTOMEL 25 MCG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LIOTHYRONINE SOD 25 MCG TAB, is $0.3191 per EA — about 40% below CYTOMEL 25 MCG TABLET.
Who manufactures CYTOMEL 25 MCG TABLET?
CYTOMEL 25 MCG TABLET (NDC 60793011601) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification